Kontigo Care Q1 2024: In line with expectations - Redeye

Redeye concludes that the reported figures mainly were in line with our expectations. While net sales exceeded projections slightly, the cost base was higher than expected due to several one-time expenses. Higher capitalized development and net sales offset the OPEX surprise, resulting in an EBIT margin of 4%, consistent with expectations. The municipal segment in Sweden remains under strain with heavily restricted budgets, resulting in a negative MRR growth of 2% q/q. We expect to maintain our fair value range with a Base case of SEK5.8.

Länk till analysen i sin helhet: https://www.redeye.se/research/1006232/kontigo-care-q1-2024-in-line-with-expectations?utm_source=finwire&utm_medium=RSS